Showing results (361-370 of 369) with videos related to

Sort By:
Pageof 37
You have reached the last page of results.This site can display upto 369 results.
Annals of Surgery|July 18, 2020
Proving the Effectiveness of the Fundamentals of Robotic Surgery (FRS) Skills Curriculum: A Single-blinded, Multispecialty, Multi-institutional Randomized Control TrialRichard M Satava, Dimitrios Stefanidis, Jeffrey S Levy, et al.
British Journal of Clinical Pharmacology|January 5, 2022
Inhaled nebulised unfractionated heparin for the treatment of hospitalised patients with COVID-19: A multicentre case series of 98 patientsFrank M P van Haren, Lex M van Loon, Anne Steins, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 25, 2025
Comparison of Human Papillomavirus genotyping by research vs. clinical assay for two self-collection devicesDiane M Harper, Alisa P Young, Marie Claire O'Dwyer, et al.
Preventive Medicine Reports|February 5, 2025
Cervical cancer screening: Impact of collection technique on human papillomavirus detection and genotypingAlisa P Young, Mutiya Olorunfemi, Leigh Morrison, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 12, 2024
Effectiveness and cost-effectiveness of online recorded recovery narratives in improving quality of life for people with non-psychotic mental health problems: a pragmatic randomized controlled trialMike Slade, Stefan Rennick-Egglestone, Rachel A Elliott, et al.
British Journal of Clinical Pharmacology|December 30, 2020
INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID-19 (INHALE-HEP): Protocol and statistical analysis plan for an investigator-initiated international metatrial of randomised studiesFrank M P van Haren, Alice Richardson, Hwan-Jin Yoon, et al.
Annals of Intensive Care|March 23, 2018
Potentially modifiable respiratory variables contributing to outcome in ICU patients without ARDS: a secondary analysis of PRoVENTFabienne D Simonis, Carmen S V Barbas, Antonio Artigas-Raventós, et al.
The Lancet. Respiratory Medicine|October 9, 2016
Epidemiological characteristics, practice of ventilation, and clinical outcome in patients at risk of acute respiratory distress syndrome in intensive care units from 16 countries (PRoVENT): an international, multicentre, prospective studyAry Serpa Neto, Carmen S V Barbas, Fabienne D Simonis, et al.
JAMA|September 3, 2020
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical TrialDerek C Angus, Lennie Derde, Farah Al-Beidh, et al.
Pageof 37